BDBM181144 US9138393, Rifampicin

SMILES CC(=O)O[C@H]1[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(/C)C(=O)Nc2c(/C=N/N3CCN(C)CC3)c(O)c3c4c(c(C)c(O)c3c2O)O[C@](C)(O/C=C/[C@H](CO)[C@H]1C)C4=O

InChI Key InChIKey=FDMGSTDXWWNIJQ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 181144   

TargetCytochrome P450 3A4(Human)
The Procter & Gamble

US Patent
LigandChemical structure of BindingDB Monomer ID 181144BDBM181144(US9138393, Rifampicin)
Affinity DataIC50: 1.00E+4nMAssay Description:A commercially available P450-GLO Assay kit (Promega Corporation, Madison Wis.) is used to screen various compounds for CYP3A4A inhibition activity. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/6/2016
Entry Details
US Patent